Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ – Biogen | Investor Relations

Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ – Biogen | Investor Relations

Source link : https://news.google.com/rss/articles/CBMivwFBVV95cUxPMFNBeG5qdXY4bGhxNjdFR0xERkhEMFFVRk1sRkJvTE94TDkzNVpnc1cyX0tFSjE5X2ZLbDlReC1TZEY1T2FZQTBsVVFhWEtESU9mY1Q3aTVBLU1NZGJBZEtRSkdNMDN1MXUwU2d5UVFqVm5zSWtOMHJJdlFmQkxpc1p4ZG9PZUl3Ymx3N2hVRHJsQXJ5Z2FOYWh1LUcyemF1d05XdUpmTkJZdFFHbkd1SUNhNUxGMThZU3dscmY3WQ?oc=5

Author :

Publish date : 2024-09-20 07:00:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version